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Immunohistochemical study of canine cutaneous histiocytoma with characterization of 
the regression and proliferation behavior in these tumors 
 
The canine cutaneous histiocytoma is a commonly encountered benign skin tumor that fre-
quently occurs in young dogs. Histiocytomas appear as rapidly growing, dome-shaped tu-
mors, mostly on the head and extremities, and often show superficial ulceration. One major 
characteristic of these tumors is the ability to undergo spontaneous regression, which is ac-
companied by massive infiltration of inflammatory cells. The aim of this study is to investi-
gate the role of the different lymphocyte populations, tumor size, ulceration, necrosis, and 
proliferation in the regression of histiocytomas. 
 
This examination is based on 191 paraffin-embedded and formalin-fixed histiocytomas from 
dogs under two years of age taken from archive material of the Institute of Veterinary Pathol-
ogy of the Freie Universität Berlin. The tumors are assigned to three different size classes (< 1 
cm2; 1-2 cm2; >2 cm2) according to their appearance on the paraffin sections. In addition, de-
gree of ulceration and necrosis are scored on an ordinal scale for each tumor from haematoxy-
lin and eosin (HE) stained slices. To date, these parameters have not been the object of inten-
sive research. In this study, the appearance of a large sample size of tumors is statistically 
evaluated and related to immunohistological results for the first time. The different subpopu-
lations of the infiltrating lymphocytes are identified immunohistochemically by specific anti-
bodies against CD3- and CD79α-antigens. It is assumed that T-lymphocytes are connected 
directly to the development and progression of self-healing. For that reason all of the 191 
histiocytomas are divided into four stages of regression on the basis of their quantity of 
CD3+-T-cells. Additionally, the quantity, distribution and relation to necrosis, ulceration and 
T-lymphocytes of infiltrating CD79+-B-cells were compared in 60 cases: 30 tumors without 
and 30 with a high degree of ulceration. Furthermore the proliferation behaviour of histiocy-
tomas through the course of regression is documented for the first time. Thereby the actively 
proliferating cells in 15 slices from each of the regression stages (I to IV) are marked with the 
antibody MIB1 in order to calculate a proliferation index.  
 
The CD79α- and MIB1-antigens are immunohistologically verified for this study by modified 
B-SA staining. Only through this method can the CD79α antibody be used reliably and suc-
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cessfully on paraffin-embedded sections. Preliminary tests show that this technique enables 
improved staining of target cells as well as better conservation of tissue structure than for-
merly established B-SA and ABC techniques. Also this modified method improves the illus-
tration of the MIB1 antibody. In the modified B-SA staining procedure slices are initially in-
cubated for 35 minutes in a water bath in Target Retrieval Solution at 95°C temperature for 
antigen demasking. Antigen pre-treatment in the water bath enables a constant and gentle 
warming of the slices and is for that reason preferred to microwave heating treatment. The 
Target Solution shows improved results compared to pre-treatment in citrat or EDTA solu-
tion. Afterwards, the slices are incubated with the respective primary antibodies for 40 min-
utes at room temperature and subsequently at 4°C overnight. The CD79α antibody is used at a 
dilution of 1:50 and the MIB1 antibody at a dilution of 1:80. 
 
The examinations show that small tumors (< 1 cm2 in diameter) originate with significantly 
higher frequency from the head and neck areas and seldom from the extremities. They also 
show statistically fewer necroses and less ulceration than larger tumors. Large histiocytomas 
(>2 cm2) have a significantly higher rate of strong ulceration (> 30 % of epithel). Also, num-
ber of necroses slightly increases with size of tumors. Immunohistological examinations dem-
onstrate a significant increase of T- and B-lymphocytes and proliferation rate in the course of 
the regression. As expected, CD3+ T-cells dominate the tumor-infiltrating lymphocytes. Their 
number within the tumor decreases significantly from periphery to the epithel. Additionally, 
necrosis increases remarkably through the course of regression. In contrast to previous stud-
ies, there are also many CD79+ B-lymphocytes found in the tissue. These correlate with the 
number of CD3+ T cells, but occur more frequently in the center of the tumor. Since symp-
toms of an advanced regression are also found in small tumors, regression presumably occurs 
at the beginning of tumor growth. No correlation is found between occurrence of secondary 
inflammation and progression of the regression. Despite of the benign nature of the histiocy-
toma, proliferation rate all over the tumor is surprisingly high, varying within the regression 
stages between 10-23 % (medians). Tumor cell proliferation at first increases significantly 
with the regression, but slowly decreases at later regression stages. Tumor size, number of 
necroses and degree of ulceration are not correlated with proliferation rate. 
 
The results indicate a relation of both tumor growth and necrosis to the regression. Moreover, 
self healing already starts at the beginning of the tumor growth and is mediated not only by T-
cell cytotoxicity but presumably also by B-cell activity. The high proliferation rate could be 
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responsible for the initiation of immunity both by an increase of tumor antigen activity as well 
as by the increased mitotic rate itself. The “aggressive” tumor growth might therefore indi-
rectly lead to its own destruction. 
 
 
